Skip to main content
Eureka 93 Inc. logo

Eureka 93 Inc. — Investor Relations & Filings

ISIN · CA2986381077 CSE Manufacturing
Open in API
Filings indexed 2 across all filing types
Latest filing 2020-03-14 Regulatory Filings
Country CA Canada
Listing CSE

About Eureka 93 Inc.

https://www.eureka93.com/

Eureka 93 Inc. is a vertically integrated life sciences company specializing in the research, development, extraction, production, processing, and distribution of cannabidiol (CBD) and hemp-based solutions. The company was formed by combining LiveWell Canada, Acenzia, and Vitality CBD Natural Health, focusing on advanced research into CBD and other cannabinoids. Eureka 93 operates as one of the largest hemp cultivation and CBD extraction operations in North America. Its core strategy is to design, develop, and deliver original, wholesome, and effective health, wellness, and beauty solutions for targeted markets, actively prototyping innovative formulations and products.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is an announcement regarding Eureka 93 Inc. filing a Notice of Intention to Make a Proposal (NOI) under the Bankruptcy and Insolvency Act, including details about court approvals, debtor-in-possession financing, and creditor claims. It is a regulatory disclosure about a material change in the company's status related to insolvency proceedings. The document does not contain financial statements, audit results, or detailed financial performance data. It is not a full report but a formal regulatory announcement about the company's restructuring process and court filings. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-03-14 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 95% confidence The document contains detailed disclosures about financial matters related to quarterly periods ending June 30, 2019 (Q2) and September 30, 2019 (Q3). It references financial statements, asset impairments, secured debt reductions, share forfeitures, and other material transactions. The presence of detailed financial data and analysis for these specific interim periods indicates this is a comprehensive financial report for a period shorter than a full fiscal year. The document is lengthy (15,000 characters) and contains substantive financial information rather than just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2020-01-07 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.